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NHS REFORMS
How do we evaluate the impact of the health reforms
on the NHS?
The Health and Social Care Bill came into force in March after much controversy, but how will we
know if it’s good for public health? Zosia Kmietowicz asks doctors, health economists, and policy
advisers
Zosia Kmietowicz
London
Even before it was put before MPs in January 2011 the Health
and Social Care Bill was steeped in controversy for the
monumental structural changes it would impose on the English
NHS. By the time it received royal assent in March 2012 the
473 pages of legislation had been subjected to the most
parliamentary scrutiny for nearly 20 years.
On the day it became law health secretary Andrew Lansley said
the act would devolve power to doctors, give more choice to
patients over how they are treated, drive up quality, enable
integration, and reduce bureaucracy in the NHS. Local
democratic involvement and public health would also be
strengthened.
But how will we know if the act is good for the public’s health?
We asked a range of doctors, health economists, and policy
advisers what measures we could usefully look at to judge the
impact of whatMike Farrar, chief executive NHSConfederation,
described as “among the toughest projects the NHS has ever
taken on.”1
Nick Black
professor of health services research, London
School of Hygiene and Tropical Medicine, and
chair, Department of Health National Advisory
Group for Clinical Audit and Enquiries,
London
It’s unlikely we will be able to determine the impact of any
healthcare reforms for at least a few years. We only have to
look back at GP fundholding to see an example of a reform that
wasn’t given long enough for clear evidence of its impact to be
rigorously determined.
Most of the government’s aspirations are motherhood and apple
pie; what’s not to like about “ensuring a focus on integration”
or “strengthening public health?” While these goals are also
notoriously difficult to measure objectively there are a couple
of aspirations that we could look at dispassionately: “drive up
quality” and “give patients more information and choice.” The
latter is alreadywell under way having started under the previous
government with NHS Choices and other initiatives. Many of
the national clinical audits provide comparisons of providers’
performance and others are joining them by adopting a policy
of public disclosure.
The principal challenge facing the government will be to
demonstrate that the quality of care (safety, effectiveness,
experience) has improved because quality in the NHS in England
has been rising rapidly over the past decade.2 In a period of, at
best, steady funding levels over the coming decade the NHS
will be doing well to maintain recent improvements. The good
news is that over the past decade national clinical databases and
patient experience surveys have been established that will be
able to determine what happens to some key aspects of
healthcare.
John Quin
consultant physician, Brighton and Sussex
University Hospitals NHS Trust, Brighton
I’ve just finished a Neo-Dickensian/Hogarthian ward round
featuring various obese Pickwickian types, brutalised neglected
Nancys, and some sodden Gin Lane funsters and the mere
possibility of the health act showing signs of success in this
double dip recession when there is no money left appears rather
over-optimistic.
I’m reliably informed that in two or three years time there will
be one of those general election things at which time modern
vox pop sampling technology will inform us on a daily, no, near
hourly, basis who favours what. And a quick glance at the
percentages will be enough to draw implications about the
success or failure of the health act. But here are some practical
improvements that would be nice to contemplate as measures
of, ahem, “success” as regards healthcare in England:
• No more scorbutic or rachitic patients on ward rounds
• No patients leaving wards to live in tents as opposed to
proper housing
• No patients waiting aeons for sheltered housing
• Comedians and pop stars forced to repay tax that can help
fund healthcare, and as an example perhaps be asked to
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help clean incontinent older patients. For a month. And
that’s the doubly incontinent.
• Moving down the Laziest Country in Europe rankings
(currently third).Then we can all hop like a frog and go out
on the street and do anything. At last we will be back in
business and we will be . . . a success.
Peter Davies
consultant chest physician, Liverpool Heart
and Chest Hospital, Liverpool
“How can I cure my patients unless I can control them,” is the
cry of Zossimov, the doctor in Fyodor Dostoyevsky’s book
Crime and Punishment and I have much sympathy with his
predicament, both as a doctor and patient.
When it became apparent that I needed to start an
anti-hypertensive drug I was grateful that my GP told me which
to start on rather than offer me a bewildering choice of perhaps
dozens. Yet when the local PCT [primary care trust] wanted me
to change to a cheaper alternative I was round to my GP’s in a
flash having seen too many people develop an intractable cough
on the cheaper alternative on offer.
I would like to see a way of assessing whether there really is
patient satisfaction in being offered a choice. I would like to
see that assessment made now and again in three to four years’
time when the new bill will have had a chance to work through
any changes in the doctor-patient power balance.
It is important because as things stand at present, patients can
be left in some uncertainty as to the best choice to make and
fear that their doctor is putting a choice to them because he or
she may not be fully informed of the relative merits of the
choices they offer. As one specialist registrar with a complex
medical problem, who had good expert knowledge of his
problem and who was offered a choice of treatment, pleaded
with me, “I just want to be managed.”
Anna Dixon
director of policy, The King’s Fund, London
The challenge in evaluating the impact of health reforms is
relating the decisions and actions taken by governments to the
performance of the health system. This is challenging because
reforms have multiple objectives, are emergent, overlaid on
previous changes, their implementation varies depending on
context and takes time, and political controversy can often colour
interpretation.
The current reforms will be difficult to evaluate but this does
not mean we shouldn’t try. As we said in our earlier response
to the white paper “the same set of proposals could lead to very
different end points depending on the process of implementation
and the actions and reactions of those working in the NHS.”
This suggests that any research evaluation will have to be
flexible and iterative tracking the reform process in real time in
a variety of different contexts.
Piloting and phased implementation enable more robust
evaluation to take place. Devolution and the consequent
divergence of healthcare systems between the four countries of
the UK also provides a natural experiment for comparing the
impact of different reforms. Currently the lack of comparative
data and standardised measurement hampers such efforts.
The current government should move quickly to fund a reform
evaluation programme that can track the impact of these reforms
so that when the next politically contentious debate starts up it
will at least be a little more informed.
Clare Gerada
chair, Royal College of General Practitioners,
London
During the Health and Social Care debate I made a comparison
between what will happen to our health service and what has
happened to our rail service. Competition in the railway, far
from reducing costs and improving quality, has resulted in
fragmentation, increased costs, and reduced services—especially
in those areas not deemed profitable enough.
General practice is already being eroded and shows early signs
of fragmentation and reduction in services. From the citizen and
patient perspective a key concern will be loss of data and ability
to measure population access and outcomes within and between
groups.
The ability to monitor and provide coordinated care to patients
is essential. Much of the act is contradictory—on the one hand
placing competition, choice andmultiproviders as corner stones,
but then emphasising the need for coordination of care,
integration, and joint working.
Another area to monitor is the cost of the reforms. These are
alreadymounting. For example, the costs of removing expensive
and scarce GPs from the consulting room to serve the
commissioning agenda will begin to show in reduced access to
GPs, reduced continuity, and increased overall NHS costs.
There is a concern too that there will be several health services
each with differing entitlements and new charges for services
once free at the point of delivery. As with social care, we need
to know these will be monitored.
Finally it would be important to monitor distribution of fair
resources, staffing, and health inequalities, but the blurring of
boundaries between public and private will make this very
difficult.
Des Spence
GP, Glasgow
This seems a simple question but it is not. “Success” will largely
depend on the parameters the government elects to measure.
The temptation will be to choose highly selective measures and
to look at crude activity data to “prove” the reforms a success.
But quantity is no measure of quality of medical care where the
best interventions are often no intervention. In addition, the
introduction of assessments invariably leads organisations to
indulge in gaming and manipulating the numbers rendering
many assessments valueless.
Perhaps there are some useful areas to assess: prescribing targets,
access to primary and secondary care, and patient and staff
satisfaction. One outcome I hope will be scrutinised in detail is
the profit sheets of the companies operating newNHS contracts.
But perhaps all my cynicism of assessments is a little premature,
for of course this is a controlled medical experiment. These
buccaneering free market reforms are only in England. In time
we will be able to make direct, independent, and valuable
comparisons between England and Scotland, Wales, and
Northern Ireland. In reality it will be a decade before we can
see the impact of these changes. Any government press release
should come with a health credibility warning. Lastly, good
healthcare is simple but unquantifiable: committed staff, a
culture of care, and most of all, no profit for intervention.
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5539 doi: 10.1136/bmj.e5539 (Published 21 August 2012) Page 2 of 4
FEATURE
Lindsey Davies
president, Faculty of Public Health, London
The transfer of public health to local authorities brings
opportunities for a more integrated approach to improving and
protecting people’s health. However, there are concerns that the
act will fragment health and care services rather than strengthen
them. The act might aim to give patients access to a wider range
of care providers, but tracking the outcomewill pose challenges.
The Faculty of Public Health (FPH) produced a risk assessment
of the act, before it became law, with four main areas of concern:
the loss of a comprehensive NHS, increased costs, reduced
quality of care, and widening health inequalities. The measures,
which could track whether these risks become reality, are largely
to be found in the work of health and wellbeing boards, their
joint strategic needs assessments, and the annual reports of
directors of public health.
Changes in health, wellbeing, and inequalities can take years
to effect and demonstrate. Short term, proxy indicators are
required. Relatively simple measures, like tracking the size of
the ring fenced public health budget and the number of directors
of public health and public health consultants and specialists in
post in England, will give an indication of whether good public
health services are being delivered.
Allyson Pollock
professor of public health research and policy
at Queen Mary, University of London
The changes being wrought by the health act are inconsistent
with planned universal, comprehensive healthcare and the
expected effects are growing differences in access to care, new
charges for services, and an expansion of corporate control over
clinical and management decision making.
The effects will be difficult to monitor. Comprehensive data
currently routinely generated through the system of public
administration will be lost under the fiendishly complex new
system. Private providers will not have the same reporting duties
as the NHS and their financial arrangements will be hidden
under a cloak of commercial confidentiality. It will become
increasingly difficult to gather systematic data about people’s
entitlements to care let alone data about the care they receive.
In these circumstances the measures of success should not be
outcomes, quality, and satisfaction ratings, each notoriously
difficult to define. Instead, the first measures of success should
focus on the public availability of information about equity of
funding, patient and service entitlements, equity of access,
population needs and planning data.
In short, the measures we need are those that will tell us the
extent to which we have retained a universal comprehensive
healthcare service. For example, what changes in access to
services and entitlement to services have occurred? What
services does each provider contribute to the NHS and under
what commercial terms?
David J Hunter
professor of health policy and management,
Durham University, Durham
I doubt that the changes made to the NHS will achieve much,
if anything, that is positive, therefore trying to identify measures
of success seems futile. The problems are threefold. Firstly,
structural changes of this nature will take a long time to settle
and require a recovery time of many years—certainly way
beyond the next election; yet, the government is seeking quick
results and evidence of improvement over the next couple of
years which, in my view, simply can’t be done in a convincing
way. Secondly, the fiscal context facing the NHS and local
government—rather than the health act—is far more likely to
be instrumental in determining any improvement (or not) in
quality or public health. Thirdly, the act is likely to result in
many of Lansley’s ambitions for the NHS going into reverse.
For example, the reforms will result in more bureaucracy and
not less; integration is likely to become more difficult and give
rise to disintegration and fragmentation; and while public health
going to local government may be the right move it has high
risks, especially in terms of improving health and wellbeing at
a time of general fiscal constraint.
I’m hugely sceptical about choice and its perceived significance.
Most people do not want to have choice in healthcare—they
want to be assured that local services are safe, accessible, and
driven by professional values and not market style ones.
Whatever happens the government will be hell bent on claiming
success for its changes if only to save face. They will most likely
seek to massage, manipulate, and twist the evidence to suit their
purposes regardless of what it might be telling them.
Jennifer Dixon
director, Nuffield Trust, London
The more pertinent question is what measures would be useful
for tracking progress of the NHS given the highly challenging
financial environment it faces over the next five years. Next to
the economic challenge, the impact of the health act will be
small.
The collection of measures in the NHS Outcomes Framework
will be a good start. But I would like to see a range of metrics
focusing on the quality of primary care. This area is relatively
unscrutinised, yet pivotal if the NHS is to reduce avoidable
hospital use.With the GP Extraction Service becoming available
next year a vast amount of information will be available to
analyse.
Information on cohorts of individuals over time would also be
useful. It is possible to link person level data on use of inpatient,
outpatient, accident and emergency, and shortly GP care in
individuals in a way that no other country can. We should use
this to track the pathways of care of cohorts of individuals to
assess whether they may be receiving optimal care, and look at
variations. In particular the care of older people who might be
avoidably bouncing to and fro across a range of providers and
social services.
Monitoring what is happening to the quality of care would also
be valuable.
Nigel Edwards
senior fellow, The King’s Fund, Leadership
Develop and Policy, London
Measuring health system performance is a poorly developed
science. Being able to attribute changes to such a wide ranging
set of reforms is even harder because the changes have created
major disruption.
We should try asmuch as possible to specify what improvements
we expect or the risk is, as always, the government will seize
on an indicator that is moving in the right direction and claim
that this is as a result of the reforms.
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The reforms should produce much more clinical input into the
design of care. If so there should be reductions in admissions
for conditions where better community management is known
to have an impact. Commissioning groups are beginning to turn
their attention to the performance of primary care which will
be commissioned nationally. So reductions in the variations in
care, in particular in referral, standardised treatment rates, use
of accident and emergency departments, and in access to primary
care might be expected.
The reforms promise increased patient choice. The extent to
which patients remember being offered choice and how far they
exercise it would indicate whether the intention of the reforms
was being met. Mapping these against changes in patient
reported outcomes would give some early clues about how far
the policy was achieving its purpose.
Another leading indicator for the success of the reforms would
be a rolling survey of clinician attitudes including their ability
to change the system they work in.
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